(E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)

C153H161BrF16N18O13 — CID 167533979

IUPAC(E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)
SMILESFc1nn(C2CCCCO2)c2ccc(/C(=C(\CC(F)(F)F)c3ccccc3)c3ccc(OC4CCCCC4)nc3)cc12.O=C(/C=C/CBr)N1CCOCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4c(c3)c(F)nn4C3CCCCO3)cn2)C1)C1CCCCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4n[nH]c(F)c4c3)cn2)C1)N1CCOCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4n[nH]c(F)c4c3)cn2)C1)N1CCOCC1
InChIInChI=1S/C42H46F4N4O3.2C35H35F4N5O3.C33H33F4N3O2.C8H12BrNO2/c43-41-34-25-31(18-20-36(34)50(48-41)39-17-7-8-24-52-39)40(35(26-42(44,45)46)29-11-3-1-4-12-29)32-19-21-38(47-27-32)53-33-15-9-22-49(28-33)23-10-16-37(51)30-13-5-2-6-14-30;2*36-34-28-20-25(10-12-30(28)41-42-34)33(29(21-35(37,38)39)24-6-2-1-3-7-24)26-11-13-31(40-22-26)47-27-8-4-14-43(23-27)15-5-9-32(45)44-16-18-46-19-17-44;34-32-26-19-23(14-16-28(26)40(39-32)30-13-7-8-18-41-30)31(27(20-33(35,36)37)22-9-3-1-4-10-22)24-15-17-29(38-21-24)42-25-11-5-2-6-12-25;9-3-1-2-8(11)10-4-6-12-7-5-10/h1,3-4,10-12,16,18-21,25,27,30,33,39H,2,5-9,13-15,17,22-24,26,28H2;2*1-3,5-7,9-13,20,22,27H,4,8,14-19,21,23H2,(H,41,42);1,3-4,9-10,14-17,19,21,25,30H,2,5-8,11-13,18,20H2;1-2H,3-7H2/b16-10+,40-35-;2*9-5+,33-29-;31-27-;2-1+/t33-,39?;2*27-;;/m111../s1
InChIKeyAIJKSDPVFSIBGD-HLDRUUGVSA-N
MW2843.96 g/mol
LogP31.95
Rot. Bonds38

About (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)

(E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one) (PubChem CID 167533979) has the molecular formula C153H161BrF16N18O13 and a molecular weight of 2843.96 g/mol. Its IUPAC name is (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one).

Molecular Properties

Compound Name(E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)
PubChem CID167533979
Molecular FormulaC153H161BrF16N18O13
Molecular Weight2843.96 g/mol
Exact Mass2841.14
IUPAC Name(E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)
SMILESFc1nn(C2CCCCO2)c2ccc(/C(=C(\CC(F)(F)F)c3ccccc3)c3ccc(OC4CCCCC4)nc3)cc12.O=C(/C=C/CBr)N1CCOCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4c(c3)c(F)nn4C3CCCCO3)cn2)C1)C1CCCCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4n[nH]c(F)c4c3)cn2)C1)N1CCOCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4n[nH]c(F)c4c3)cn2)C1)N1CCOCC1
InChIInChI=1S/C42H46F4N4O3.2C35H35F4N5O3.C33H33F4N3O2.C8H12BrNO2/c43-41-34-25-31(18-20-36(34)50(48-41)39-17-7-8-24-52-39)40(35(26-42(44,45)46)29-11-3-1-4-12-29)32-19-21-38(47-27-32)53-33-15-9-22-49(28-33)23-10-16-37(51)30-13-5-2-6-14-30;2*36-34-28-20-25(10-12-30(28)41-42-34)33(29(21-35(37,38)39)24-6-2-1-3-7-24)26-11-13-31(40-22-26)47-27-8-4-14-43(23-27)15-5-9-32(45)44-16-18-46-19-17-44;34-32-26-19-23(14-16-28(26)40(39-32)30-13-7-8-18-41-30)31(27(20-33(35,36)37)22-9-3-1-4-10-22)24-15-17-29(38-21-24)42-25-11-5-2-6-12-25;9-3-1-2-8(11)10-4-6-12-7-5-10/h1,3-4,10-12,16,18-21,25,27,30,33,39H,2,5-9,13-15,17,22-24,26,28H2;2*1-3,5-7,9-13,20,22,27H,4,8,14-19,21,23H2,(H,41,42);1,3-4,9-10,14-17,19,21,25,30H,2,5-8,11-13,18,20H2;1-2H,3-7H2/b16-10+,40-35-;2*9-5+,33-29-;31-27-;2-1+/t33-,39?;2*27-;;/m111../s1
InChIKeyAIJKSDPVFSIBGD-HLDRUUGVSA-N
XLogP31.95
TPSA315.35 Ų
H-Bond Donors2
H-Bond Acceptors26
Rotatable Bonds38
Heavy Atoms201
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002843.96
LogP ≤ 531.95
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'stilbene', 'substructure': 'N/A'}

Analyze (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)?
The IUPAC name of (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one) (CID 167533979) is (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one).
What is the SMILES notation for (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)?
The canonical SMILES for (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one) is Fc1nn(C2CCCCO2)c2ccc(/C(=C(\CC(F)(F)F)c3ccccc3)c3ccc(OC4CCCCC4)nc3)cc12.O=C(/C=C/CBr)N1CCOCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4c(c3)c(F)nn4C3CCCCO3)cn2)C1)C1CCCCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4n[nH]c(F)c4c3)cn2)C1)N1CCOCC1.O=C(/C=C/CN1CCC[C@@H](Oc2ccc(/C(=C(/CC(F)(F)F)c3ccccc3)c3ccc4n[nH]c(F)c4c3)cn2)C1)N1CCOCC1.
What is the InChIKey of (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)?
The InChIKey is AIJKSDPVFSIBGD-HLDRUUGVSA-N. The full InChI is InChI=1S/C42H46F4N4O3.2C35H35F4N5O3.C33H33F4N3O2.C8H12BrNO2/c43-41-34-25-31(18-20-36(34)50(48-41)39-17-7-8-24-52-39)40(35(26-42(44,45)46)29-11-3-1-4-12-29)32-19-21-38(47-27-32)53-33-15-9-22-49(28-33)23-10-16-37(51)30-13-5-2-6-14-30;2*36-34-28-20-25(10-12-30(28)41-42-34)33(29(21-35(37,38)39)24-6-2-1-3-7-24)26-11-13-31(40-22-26)47-27-8-4-14-43(23-27)15-5-9-32(45)44-16-18-46-19-17-44;34-32-26-19-23(14-16-28(26)40(39-32)30-13-7-8-18-41-30)31(27(20-33(35,36)37)22-9-3-1-4-10-22)24-15-17-29(38-21-24)42-25-11-5-2-6-12-25;9-3-1-2-8(11)10-4-6-12-7-5-10/h1,3-4,10-12,16,18-21,25,27,30,33,39H,2,5-9,13-15,17,22-24,26,28H2;2*1-3,5-7,9-13,20,22,27H,4,8,14-19,21,23H2,(H,41,42);1,3-4,9-10,14-17,19,21,25,30H,2,5-8,11-13,18,20H2;1-2H,3-7H2/b16-10+,40-35-;2*9-5+,33-29-;31-27-;2-1+/t33-,39?;2*27-;;/m111../s1.
What are the key properties of (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one)?
(E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one) has a molecular weight of 2843.96 g/mol, XLogP of 31.95, 38 rotatable bonds, 2 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-4-bromo-1-morpholin-4-ylbut-2-en-1-one;5-[(Z)-1-(6-cyclohexyloxy-3-pyridinyl)-4,4,4-trifluoro-2-phenylbut-1-enyl]-3-fluoro-1-(oxan-2-yl)indazole;(E)-1-cyclohexyl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-[3-fluoro-1-(oxan-2-yl)indazol-5-yl]-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one;bis((E)-1-morpholin-4-yl-4-[(3R)-3-[[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]-2-pyridinyl]oxy]piperidin-1-yl]but-2-en-1-one) is sourced from PubChem (CID 167533979), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).